Par Drugs & Chemicals Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 27.43 | 32.22 | 19.97 |
| Operating Expense | 22.93 | 24.90 | 18.17 |
| Net Profit | 2.63 | 4.71 | 0.85 |
| Net Profit Margin | 9.59% | 14.62% | 4.26% |
| Earning Per Share | 2.14 | 3.83 | 0.69 |
| EBIDTA | 4.51 | 7.31 | 2.13 |
| Effective Tax Rate | 20.44% | 22.13% | 17.22% |
Particulars
Sep 2026
Revenue27.43
Operating Expense22.93
Net Profit2.63
Net Profit Margin9.59
Earning Per Share2.14
EBIDTA4.51
Effective Tax Rate20.44
